For the second month straight, activity in the Biotechnology sector led the health care M&A market. In a slow month which saw a total of only 53 deals announced, the Biotech sector accounted for nine deals, or 17% of the total. Based on prices revealed to date,...
No matter what kind of senior care facility you operate—skilled nursing, assisted living, independent living—the past few years have been a very difficult operating environment. Oddly, however, the financial woes of the senior care industry seemed to have had little...
Our choice for Deal of the Month carries the largest price tag for February, and reflects a recent surge of interest in the Biotechnology sector. It is the largest deal this sector has seen since Amgen (NASDAQ: AMGN) acquired Immunex for $11.1 billion last year. After...
The fourth quarter capped 2002 with a surge of M&A activity not seen in four years. A total of 286 transactions were announced in 13 sectors of the health care industry. Although some of this volume may come from dealmakers’ desire to close deals and improve...
As the year began, it looked as if the worst was behind us. Genesis Health Ventures (NASDAQ: GHVI) and Kindred Healthcare (NYSE: KIND), having emerged from Chapter 11 bankruptcy the year before, appeared to be on healthy ground, and Assisted Living Concepts (NASDAQ:...
By several measures, it was a good year for health care M&A activity. At the date of this issue, a total of 895 transactions have been announced in the health care industry. With two weeks left in 2002, the year will surpass 900 deals. This figure represents a...